| Author (Corporate) | EurActiv |
|---|---|
| Series Title | EurActiv |
| Series Details | 15.9.09 |
| Publication Date | 15/09/2009 |
| Content Type | News |
|
The Innovative Medicines Initiative is a unique Public-Private Partnership (PPP) between the pharmaceutical industry represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Communities represented by the European Commission. The IMI issued its second call for proposals, September 2009. With these topics, IMI aims to accelerate the discovery and development of new medicines in the field of cancer, inflammatory and infectious disease. The funding available for the 2nd call will be €156.3 million, with €76.8 million provided by the European Commission and €79.5 million expected to be provided in kind from EFPIA member companies. IMI also introduced also its newly-appointed Executive Director, Michel Goldman, who will officially take up his post on 16 September 2009. |
|
| Source Link | http://www.euractiv.com/innovation-enterprise/eu-inject-millions-developing-in-news-222551 |
| Related Links |
|
| Subject Categories | Business and Industry, Culture, Education and Research, Health |
| Countries / Regions | Europe |
